Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2025 05:00 ET | Source: 4TEEN4 Pharmaceuticals GmbH

4TEEN4 Extends Series C Financing Round to €55 Million, Supporting Expanded Clinical Development of Procizumab in Cardiogenic Shock

4TEEN4 extends series C financing to EUR 55M ($64M) to increase footprint of the Phase 2a study across Europe and to support planned expansion into US.